Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer
Phase 1
- Conditions
- Smoldering Multiple Myeloma (sMM)Acute Myelogenous Leukemia (AML)Multiple Myeloma (MM)Myelodysplastic Syndrome (MDS)
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Benovus Bio, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT02240537
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Virginia Cancer Specialists, Fairfax, Virginia, United States
News
No news found